Everolimus
Everolimus is a derivative of sirolimus. Everolimus works similarly to Rapamycin as an mTOR inhibitor. Everolimus is in the FDA approval process and is expected to be approved in 2009.
Department: Mass Spectrometry Lab
Methodology: HPLC and tandem mass spectrometry (MS/MS)
Sample:
• Whole blood (EDTA) lavender top – 250ul
Handling:
Whole blood – freeze and store at -20ºC until shipped
Shipping:
• Whole blood - Ship sample overnight with 3-4 lbs of dry ice using a guaranteed overnight courier.
Special Notes: This research test must be coordinated through the Mass Spectrometry Laboratory Director. Most research tests are performed on a batch basis; the laboratory will not perform single sample testing. Contact the Mass Spectrometry Laboratory Director for more information.
Turnaround Time and Test Cost: Contact the Mass Spectrometry Laboratory Director.
Related Tests: Sirolimus (Rapamycin), Cyclosporin A, Tacrolimus (FK506) |
Baylor Intranet | 
Baylor Portal